Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Clements

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|April 26, 2011
Dengue vaccines: progress and challengesBeth-Ann G Coller, David E Clements
Idrugs : the Investigational Drugs Journal|December 15, 2010
Advances in flavivirus vaccine developmentBeth-Ann G Coller, David E Clements, Timothy Martyak, et al.
Plos One|September 21, 2011
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccinesKae M Pusic, Caryn N Hashimoto, Axel Lehrer, et al.
Vaccine|July 23, 2011
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseBeth-Ann G Coller, David E Clements, Andrew J Bett, et al.
Vaccine|July 7, 2015
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primatesDhanasekaran Govindarajan, Steven Meschino, Liming Guan, et al.
Viruses|February 28, 2023
Differences in Genetic Diversity of Mammalian Tick-Borne FlavivirusesKassandra L Carpio, Jill K Thompson, Steven G Widen, et al.
The American Journal of Tropical Medicine and Hygiene|May 21, 2026
A Phase 1, Open Label, Safety Study of HBV-002 (West Nile Recombinant Subunit Vaccine) in Healthy AdultsBeth-Ann G Coller, David E Clements, Michele Yelmene, et al.
Vaccine|February 21, 2017
Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in miceAxel T Lehrer, Teri-Ann S Wong, Michael M Lieberman, et al.
Vaccine|October 28, 2006
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitisDouglas M Watts, Robert B Tesh, Marina Siirin, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in miceChih-Yun Lai, Albert To, Teri Ann S Wong, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|April 26, 2011
Dengue vaccines: progress and challengesBeth-Ann G Coller, David E Clements
Idrugs : the Investigational Drugs Journal|December 15, 2010
Advances in flavivirus vaccine developmentBeth-Ann G Coller, David E Clements, Timothy Martyak, et al.
Plos One|September 21, 2011
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccinesKae M Pusic, Caryn N Hashimoto, Axel Lehrer, et al.
Vaccine|July 23, 2011
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseBeth-Ann G Coller, David E Clements, Andrew J Bett, et al.
Vaccine|July 7, 2015
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primatesDhanasekaran Govindarajan, Steven Meschino, Liming Guan, et al.
Viruses|February 28, 2023
Differences in Genetic Diversity of Mammalian Tick-Borne FlavivirusesKassandra L Carpio, Jill K Thompson, Steven G Widen, et al.
The American Journal of Tropical Medicine and Hygiene|May 21, 2026
A Phase 1, Open Label, Safety Study of HBV-002 (West Nile Recombinant Subunit Vaccine) in Healthy AdultsBeth-Ann G Coller, David E Clements, Michele Yelmene, et al.
Vaccine|February 21, 2017
Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in miceAxel T Lehrer, Teri-Ann S Wong, Michael M Lieberman, et al.
Vaccine|October 28, 2006
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitisDouglas M Watts, Robert B Tesh, Marina Siirin, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in miceChih-Yun Lai, Albert To, Teri Ann S Wong, et al.
Pageof 2